$18.69
-0.06-0.32%
Last update: Oct 30, 4:54 PM
Faeth Therapeutics Inc
FTHNASDAQ
Faeth Therapeutics (FTH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-4.77 | $-0.62 | $-4.81 | $-4.11 |
| Actual | $-2.84 | $-131.45 | $-3.74 | $-3.62 |
| Surprise | +40.5% | -21101.6% | +22.3% | +11.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.70 | $-0.76 | $-0.64 | $-0.66 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-2.84 | $-4.77 | 40.5 % |
| Q1 | May 15, 2026 | $-131.45 | $-0.62 | -21101.6 % |
| Q4 | Mar 30, 2026 | $-3.74 | $-4.81 | 22.3 % |
| Q3 | Nov 14, 2025 | $-3.62 | $-4.11 | 11.9 % |
